Page last updated: 2024-11-05

todralazine and Mitral Valve Insufficiency

todralazine has been researched along with Mitral Valve Insufficiency in 1 studies

Todralazine: An antihypertensive agent with both central and peripheral action; it has some central nervous system depressant effects.

Mitral Valve Insufficiency: Backflow of blood from the LEFT VENTRICLE into the LEFT ATRIUM due to imperfect closure of the MITRAL VALVE. This can lead to mitral valve regurgitation.

Research Excerpts

ExcerptRelevanceReference
"We evaluated long-term combined vasodilator therapy (hydralazine or ecarazine + isosorbide dinitrate) in 29 patients with chronic congestive heart failure resistant to the optimal conventional therapy."3.67Ambulatory long-term vasodilator therapy for chronic refractory heart failure: hemodynamic evaluation and clinical response. ( Hatano, M; Hibiya, K; Ichikawa, M; Nagasawa, M; Ozawa, Y; Saito, S; Tamura, Y; Tomobe, K; Yumikura, S, 1984)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saito, S1
Ichikawa, M1
Ozawa, Y1
Yumikura, S1
Nagasawa, M1
Hibiya, K1
Tamura, Y1
Tomobe, K1
Hatano, M1

Other Studies

1 other study available for todralazine and Mitral Valve Insufficiency

ArticleYear
Ambulatory long-term vasodilator therapy for chronic refractory heart failure: hemodynamic evaluation and clinical response.
    Japanese circulation journal, 1984, Volume: 48, Issue:4

    Topics: Adult; Aged; Ambulatory Care; Cardiac Catheterization; Cardiomyopathy, Dilated; Chronic Disease; Dru

1984